How did IRMD's revenue and expenses trend in Q4 2024?

Iradimed (IRMD) experienced a revenue increase of 4.37% in Q4 2024, with the total revenue amounting to $19.39 million. However, the company also saw a rise in certain expenses, including a 5.99% increase in Operating Expenses, which reached $8.39 million, and a 6.75% increase in Research and Development Expenses, totaling $569,993. The Cost of Goods Sold remained at $4.63 million, which is a 4.37% increase from the previous quarter. |code|Ticker|Name|Date|Selling, General, and Administrative Expenses|R&D Expenses|Total Revenue|Operating Expenses|market_code| |---|---|---|---|---|---|---|---|---| |IRMD|IRMD.O|Iradimed|2024 Q1|7818376|821000|1.7598119E7||185| |IRMD|IRMD.O|Iradimed|2024 Q2|7581421|801129|1.7928876E7||185| |IRMD|IRMD.O|Iradimed|2024 Q3|7763119|639467|1.8325959E7||185| |IRMD|IRMD.O|Iradimed|2024 Q4|8390649|569993|1.9389167E7||185|